Zhuang X - Search Results

1

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.

Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, Santos DP, Blanz J, Obermaier CD, Strojny C, Savas JN, Kiskinis E, Zhuang X, Krüger R, Surmeier DJ, Krainc D. Burbulla LF, et al. Among authors: zhuang x. Science. 2017 Sep 22;357(6357):1255-1261. doi: 10.1126/science.aam9080. Epub 2017 Sep 7. Science. 2017. PMID: 28882997 Free PMC article.

2

Transgenic mouse models of dopamine deficiency.

Chen L, Zhuang X. Chen L, et al. Among authors: zhuang x. Ann Neurol. 2003;54 Suppl 6:S91-102. doi: 10.1002/ana.10655. Ann Neurol. 2003. PMID: 12891659 Review.

3

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice.

Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X. Chen L, et al. Among authors: zhuang x. J Biol Chem. 2005 Jun 3;280(22):21418-26. doi: 10.1074/jbc.M413955200. Epub 2005 Mar 30. J Biol Chem. 2005. PMID: 15799973 Free article.

4

Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice.

Yang W, Chen L, Ding Y, Zhuang X, Kang UJ. Yang W, et al. Among authors: zhuang x. Hum Mol Genet. 2007 Dec 1;16(23):2900-10. doi: 10.1093/hmg/ddm249. Epub 2007 Sep 6. Hum Mol Genet. 2007. PMID: 17823202

5

The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells.

Shim JH, Yoon SH, Kim KH, Han JY, Ha JY, Hyun DH, Paek SH, Kang UJ, Zhuang X, Son JH. Shim JH, et al. Among authors: zhuang x. Mitochondrion. 2011 Sep;11(5):707-15. doi: 10.1016/j.mito.2011.05.013. Epub 2011 Jun 2. Mitochondrion. 2011. PMID: 21664494

6

Aberrant plasticity and "learned" motor inhibition in Parkinson's disease.

Zhuang XX. Zhuang XX. Sheng Li Xue Bao. 2012 Oct 25;64(5):543-9. Sheng Li Xue Bao. 2012. PMID: 23090495 Free article.

7

A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease.

Beeler JA, Frank MJ, McDaid J, Alexander E, Turkson S, Bernardez Sarria MS, McGehee DS, Zhuang X. Beeler JA, et al. Among authors: zhuang x. Cell Rep. 2012 Dec 27;2(6):1747-61. doi: 10.1016/j.celrep.2012.11.014. Epub 2012 Dec 13. Cell Rep. 2012. PMID: 23246005 Free PMC article.

8

The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Zhuang X, Mazzoni P, Kang UJ. Zhuang X, et al. Nat Rev Neurol. 2013 May;9(5):248-56. doi: 10.1038/nrneurol.2013.57. Epub 2013 Apr 16. Nat Rev Neurol. 2013. PMID: 23588357 Review.

9

Nicotinic receptors regulate the dynamic range of dopamine release in vivo.

Koranda JL, Cone JJ, McGehee DS, Roitman MF, Beeler JA, Zhuang X. Koranda JL, et al. Among authors: zhuang x. J Neurophysiol. 2014 Jan;111(1):103-11. doi: 10.1152/jn.00269.2013. Epub 2013 Oct 2. J Neurophysiol. 2014. PMID: 24089398 Free PMC article.

10

A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.

Chen L, Xie Z, Turkson S, Zhuang X. Chen L, et al. Among authors: zhuang x. J Neurosci. 2015 Jan 21;35(3):890-905. doi: 10.1523/JNEUROSCI.0089-14.2015. J Neurosci. 2015. PMID: 25609609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,262 results

Search Page